Generic, Biosimilar and Value Added Medicines Industry Leaders Join Forces to Drive Access to Medicines Agenda

9 June 2016

During the next two days, the key pharmaceutical industry leaders […]

Value Added Medicines: Rethink, Reinvent & Optimise Medicines, Improving Patient Health & Access

31 May 2016

A new study Value Added Medicines: Rethink, Reinvent & Optimise […]

Value Added Medicines: Rethink, Reinvent & Optimise Medicines, Improving Patient Health & Access / 31 May 2016 17:30 – 19:30, European Parliament

4 May 2016

Medicines for Europe Reinforces its Commitment to Promote Universal Access to Health

19 April 2016

Over 100 participants will explore different ways and opportunities to […]

EGA becomes Medicines for Europe

10 March 2016

The European Generic and Biosimilar Medicines Association is now Medicines […]

Launch of European Value Added medicines (EVA), a new EGA sector group, will deliver efficiency

12 June 2015

Brussels – The European Generic and Biosimilar medicines Association (EGA) announced […]